205 related articles for article (PubMed ID: 8063046)
1. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors.
Reynisdottir S; Wahrenberg H; Carlström K; Rössner S; Arner P
Diabetologia; 1994 Apr; 37(4):428-35. PubMed ID: 8063046
[TBL] [Abstract][Full Text] [Related]
2. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P
Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
[TBL] [Abstract][Full Text] [Related]
5. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome.
Faulds G; Rydén M; Ek I; Wahrenberg H; Arner P
J Clin Endocrinol Metab; 2003 May; 88(5):2269-73. PubMed ID: 12727985
[TBL] [Abstract][Full Text] [Related]
7. Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction.
Löfgren P; Hoffstedt J; Näslund E; Wirén M; Arner P
Diabetologia; 2005 Nov; 48(11):2334-42. PubMed ID: 16222518
[TBL] [Abstract][Full Text] [Related]
8. The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis.
Rydén M; Hoffstedt J; Eriksson P; Bringman S; Arner P
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1599-603. PubMed ID: 11753577
[TBL] [Abstract][Full Text] [Related]
9. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
Hoffstedt J; Arner P; Hellers G; Lönnqvist F
J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying regional variations of catecholamine-induced lipolysis in rat adipocytes.
Tavernier G; Galitzky J; Valet P; Remaury A; Bouloumie A; Lafontan M; Langin D
Am J Physiol; 1995 Jun; 268(6 Pt 1):E1135-42. PubMed ID: 7611389
[TBL] [Abstract][Full Text] [Related]
11. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.
Reynisdottir S; Ellerfeldt K; Wahrenberg H; Lithell H; Arner P
J Clin Invest; 1994 Jun; 93(6):2590-9. PubMed ID: 8200997
[TBL] [Abstract][Full Text] [Related]
12. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
Lönnqvist F; Wahrenberg H; Hellström L; Reynisdottir S; Arner P
J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970
[TBL] [Abstract][Full Text] [Related]
13. Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity.
Reynisdottir S; Langin D; Carlström K; Holm C; Rössner S; Arner P
Clin Sci (Lond); 1995 Oct; 89(4):421-9. PubMed ID: 7493443
[TBL] [Abstract][Full Text] [Related]
14. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)].
Berlan M; Lafontan M; Dang Tran L
J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915
[TBL] [Abstract][Full Text] [Related]
15. Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells.
Engfeldt P; Hellmér J; Wahrenberg H; Arner P
J Biol Chem; 1988 Oct; 263(30):15553-60. PubMed ID: 2844816
[TBL] [Abstract][Full Text] [Related]
16. Is visceral adiposity a significant correlate of subcutaneous adipose cell lipolysis in men?
Mauriège P; Brochu M; Prud'homme D; Tremblay A; Nadeau A; Lemieux S; Després JP
J Clin Endocrinol Metab; 1999 Feb; 84(2):736-42. PubMed ID: 10022446
[TBL] [Abstract][Full Text] [Related]
17. Regional differences in adipose tissue lipolysis from lean and obese women: existence of postreceptor alterations.
Mauriège P; Prud'homme D; Lemieux S; Tremblay A; Després JP
Am J Physiol; 1995 Aug; 269(2 Pt 1):E341-50. PubMed ID: 7653551
[TBL] [Abstract][Full Text] [Related]
18. Elevated beta2-adrenoceptor protein concentration in adipose tissue from obese subjects is closely related to the body mass index and waist/hip ratio.
Rasmussen M; Almdal T; Bratholm P; Christensen NJ
Clin Sci (Lond); 2003 Feb; 104(2):93-102. PubMed ID: 12546631
[TBL] [Abstract][Full Text] [Related]
19. Differences in lipolysis between human subcutaneous and omental adipose tissues.
Arner P
Ann Med; 1995 Aug; 27(4):435-8. PubMed ID: 8519504
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.
Wahrenberg H; Ek I; Reynisdottir S; Carlström K; Bergqvist A; Arner P
J Clin Endocrinol Metab; 1999 Jun; 84(6):2182-7. PubMed ID: 10372729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
